ANDROGENIC ALOPECIA

This study tests whether tiny particles from umbilical cord stem cells (called exosomes) can safely and effectively regrow hair in young men with male pattern baldness. About 59 men aged 18-35 will receive either the exosome injections or the standard treatment minoxidil. The goa…

This study tests a new topical treatment called TH07 for male pattern baldness. About 420 men aged 18-49 will apply TH07, standard minoxidil, or a placebo daily for 24 weeks. Researchers will measure hair count and thickness to see if TH07 works better than existing options.

This study tests whether injecting a substance made from a person's own hair follicles can safely and effectively regrow hair in people with male or female pattern baldness. Sixty adults who are already on stable hair loss medication will receive injections into their scalp over …

This study tests whether tiny particles from umbilical cord stem cells, delivered through microneedles, can safely help regrow hair in men with male pattern baldness. 18 men aged 18-60 with mild to moderate hair loss will receive the treatment. The goal is to see if this cell-fre…

This study compares a new hydrogel made from 2-Deoxy-D-ribose to the standard minoxidil 5% solution for treating mild to moderate hair loss in adults aged 18 to 50. Sixty participants will apply either the gel or minoxidil daily for 6 months. Researchers will measure hair density…

This study examines a protein called JAK2 in the scalps of 25 men with male pattern baldness. Researchers will compare JAK2 levels in balding and non-balding areas, then see if 3 months of topical minoxidil 5% changes JAK2 in balding scalp. The goal is to understand the biology b…